+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Meningitis Drug"

Pneumococcal Meningitis - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Pneumococcal Meningitis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • May 2024
  • 63 Pages
  • Global
From
Meningitis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Meningitis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 398 Pages
  • Global
From
Vancomycin - Global Strategic Business Report - Product Thumbnail Image

Vancomycin - Global Strategic Business Report

  • Report
  • April 2025
  • 78 Pages
  • Global
From
From
From
From
From
From
From
Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Meningitis - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Neisseria Meningitides Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Neisseria Meningitides Meningitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cryptococcal Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Cryptococcal Meningitis - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Bacterial Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Meningitis - Pipeline Insight, 2025

  • Report
  • April 2025
  • 60 Pages
  • Global
From
Meningitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Meningitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Bacterial Meningitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Bacterial Meningitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cryptococcal Meningitis (CM) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cryptococcal Meningitis (CM) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Loading Indicator

Meningitis is an inflammation of the membranes that cover the brain and spinal cord. Meningitis drugs are used to treat the infection and reduce the risk of complications. These drugs are typically antibiotics, antivirals, or antifungals, and may be administered orally, intravenously, or intramuscularly. Commonly used antibiotics include cefotaxime, ceftriaxone, and vancomycin. Antivirals such as acyclovir and valacyclovir are used to treat viral meningitis, while antifungals such as amphotericin B and fluconazole are used to treat fungal meningitis. Meningitis drugs are part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological conditions. These drugs are used to treat conditions such as epilepsy, multiple sclerosis, Parkinson's disease, and Alzheimer's disease. Some companies in the Meningitis Drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more